Lithuanian HealthTech startup, Pulsetto, has secured a €2 million investment from Scalewolf for its wearable tech that uses vagus nerve stimulation (VNS) for stress relief, mental resilience, and sleep optimization.
This investment marks Pulsetto's expansion into defense applications, aiming to help soldiers and frontline personnel manage stress and mental fatigue.
Pulsetto's VNS device stimulates the vagus nerve with electrical impulses, helping individuals shift from 'fight or flight' to a state of relaxation and rest.
The partnership with Scalewolf, a dual-use technology accelerator and VC fund, highlights the increasing demand for dual-use innovations that enhance both civilian well-being and national security.